Romain Verpillot
Alstom (France)(FR)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Lipid Membrane Structure and Behavior, Gene expression and cancer classification, Advanced Biosensing Techniques and Applications, Supramolecular Self-Assembly in Materials
Most-Cited Works
- → PEGylated Nanoparticles Bind to and Alter Amyloid-Beta Peptide Conformation: Toward Engineering of Functional Nanomedicines for Alzheimer’s Disease(2012)181 cited
- → New Method Based on Capillary Electrophoresis with Laser-Induced Fluorescence Detection (CE-LIF) to Monitor Interaction between Nanoparticles and the Amyloid-β Peptide(2010)53 cited
- → Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of Alzheimer's disease(2008)42 cited
- → Microchip Electrophoresis Profiling of Aβ Peptides in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease(2010)42 cited
- → Correlation between cognition and plasma noradrenaline level in Alzheimer’s disease: a potential new blood marker of disease evolution(2020)34 cited
- → Analysis of Amyloid-β Peptides in Cerebrospinal Fluid Samples by Capillary Electrophoresis Coupled with LIF Detection(2011)32 cited
- → Development of a magnetic immunosorbent for on-chip preconcentration of amyloid β isoforms: Representatives of Alzheimer’s disease biomarkers(2012)31 cited
- → Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization(2011)29 cited
- → New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids(2021)24 cited
- → Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-β peptide(2011)23 cited